MDVerse
MDVerse drives personalized, precision therapies by pairing next-generation software, analytics, and generative AI with tailor-made therapeutics. They aim to enable the revolution in advanced therapies by leveraging their software, analytics, and AI/ML with industry best practices to ensure precision therapeutics are delivered within the entire ATMP ecosystem. The company addresses the problem of clinical supply leaders lacking confidence in their ability to supply cell and gene therapy trials. MDVerse integrates drug creators, pharma, CDMOs, academia, clinical sites, and the materials ecosystem, providing solutions for supply chain optimization, real-time demand-supply alignment, and clinical trial intelligence. Their business model likely involves SaaS or licensing of their software platform to support the advanced therapy ecosystem.
MDVerse
MDVerse drives personalized, precision therapies by pairing next-generation software, analytics, and generative AI with tailor-made therapeutics. They aim to enable the revolution in advanced therapies by leveraging their software, analytics, and AI/ML with industry best practices to ensure precision therapeutics are delivered within the entire ATMP ecosystem. The company addresses the problem of clinical supply leaders lacking confidence in their ability to supply cell and gene therapy trials. MDVerse integrates drug creators, pharma, CDMOs, academia, clinical sites, and the materials ecosystem, providing solutions for supply chain optimization, real-time demand-supply alignment, and clinical trial intelligence. Their business model likely involves SaaS or licensing of their software platform to support the advanced therapy ecosystem.